These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22884663)

  • 41. [Epidemiological characteristic of Varicella and Varicella-Zoster virus genotype in Minhang District of Shanghai].
    Du Y; Jiang LF; Zhang LP
    Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):327-9. PubMed ID: 20077731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of varicella vaccine on varicella-zoster virus dynamics.
    Schmid DS; Jumaan AO
    Clin Microbiol Rev; 2010 Jan; 23(1):202-17. PubMed ID: 20065330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccine-era varicella epidemiology and vaccine effectiveness in a public elementary school population, 2002-2007.
    Lee LE; Ho H; Lorber E; Fratto J; Perkins S; Cieslak PR
    Pediatrics; 2008 Jun; 121(6):e1548-54. PubMed ID: 18519459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Varicella outbreak trends in school settings during the voluntary single-dose vaccine era from 2006 to 2017 in Shanghai, China.
    Wu QS; Wang X; Liu JY; Chen YF; Zhou Q; Wang Y; Sha JD; Xuan ZL; Zhang LW; Yan L; Hu Y
    Int J Infect Dis; 2019 Dec; 89():72-78. PubMed ID: 31521857
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiology of varicella in Connecticut, 2001-2005.
    Sosa LE; Hadler JL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S90-3. PubMed ID: 18419416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effectiveness of varicella vaccine in China.
    Fu C; Wang M; Liang J; Xu J; Wang C; Bialek S
    Pediatr Infect Dis J; 2010 Aug; 29(8):690-3. PubMed ID: 20216242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effectiveness on post-exposure vaccination of varicella and its influencing factors in elementary schools in Beijing].
    Ma R; Sun MP; Sun M; Hou WJ; Jiang GY; Peng XH; Wu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):559-63. PubMed ID: 19957618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015.
    Rieck T; Feig M; An der Heiden M; Siedler A; Wichmann O
    Euro Surveill; 2017 Apr; 22(17):. PubMed ID: 28488996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.
    Chaves SS; Zhang J; Civen R; Watson BM; Carbajal T; Perella D; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S127-31. PubMed ID: 18419385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of vaccine-induced immunity to varicella over time.
    Chaves SS; Gargiullo P; Zhang JX; Civen R; Guris D; Mascola L; Seward JF
    N Engl J Med; 2007 Mar; 356(11):1121-9. PubMed ID: 17360990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Varicella vaccine effectiveness in the US vaccination program: a review.
    Seward JF; Marin M; Vázquez M
    J Infect Dis; 2008 Mar; 197 Suppl 2():S82-9. PubMed ID: 18419415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of second-dose varicella vaccination as post-exposure prophylaxis: a prospective cohort study.
    Wu Q; Liu J; Wang Y; Zhou Q; Wang X; Xuan Z; Zhang L; Gao Y; Chen B; Hu Y
    Clin Microbiol Infect; 2019 Jul; 25(7):872-877. PubMed ID: 30472425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
    Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
    Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metaanalysis of vaccine effectiveness in varicella outbreaks.
    Bayer O; Heininger U; Heiligensetzer C; von Kries R
    Vaccine; 2007 Sep; 25(37-38):6655-60. PubMed ID: 17706845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster.
    Brisson M; Melkonyan G; Drolet M; De Serres G; Thibeault R; De Wals P
    Vaccine; 2010 Apr; 28(19):3385-97. PubMed ID: 20199763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.